Theres no benefit to pushing through severe symptoms
With continued research and collaboration between academia, industry, and clinicians, GLP-1based interventions have the potential to address complex metabolic diseases more comprehensively, shaping the next generation of treatments and improving outcomes for patients worldwide
The evidence is mostly clinical observation and patient-reported outcomes
Ontario-based laboratory research supply Research Peptides Canada Nordexa supplies laboratory research reagents from Ontario, with tracked shipping across Canada and batch-specific analytical documentation available on applicable product pages
And if GLP-1s arent the best fit, well explore other evidence-based options with you
While most of our sample (60.6%) indicate they have never used a GLP-1 medication, 12.0% said they are currently using a GLP-1 medication, and 7.9% said they utilized a GLP-1 drug previously